Mark W. Sawicki - 14 Mar 2026 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Scientific Officer
Signature
/s/ Mark Sawicki
Issuer symbol
CYRX
Transactions as of
14 Mar 2026
Net transactions value
-$25,880
Form type
4
Filing time
17 Mar 2026, 20:00:11 UTC
Previous filing
26 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sawicki Mark W Chief Scientific Officer C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD /s/ Mark Sawicki 17 Mar 2026 0001848218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Award +22,845 +27% $0.000000* 106,932 14 Mar 2026 Direct F1
transaction CYRX Common Stock Sale $25,880 -3,235 -3% $8.00 103,697 16 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Award +68,534 $0.000000* 68,534 14 Mar 2026 Common Stock 68,534 $8.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
F2 Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F3 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.